O-Tolylamine

O-Tolylamine

SCHEMBL578081

Cc1ccccc1[NH3+].Fc1c(F)c(F)c([B-](c2c(F)c(F)c(F)c(F)c2F)(c2c(F)c(F)c(F)c(F)c2F)c2c(F)c(F)c(F)c(F)c2F)c(F)c1F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.38
HTT P42858 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148465 0.85 TRPA1 (0.33) ACHETSHR
O-Xylene SCHEMBL30386408 0.83 TSHR (0.48) ACHEHTTKDM4CTSHR
O-Xylene SCHEMBL30509215 0.83 TSHR (0.48) ACHEHTTKDM4CTSHR
SCHEMBL1452264 0.82 ACHE (0.34) ACHEHTTKDM4CTSHR
SCHEMBL4942420 0.79
SCHEMBL6609964 0.78 ACHE (0.37) ACHEHTTKDM4CTSHR
SCHEMBL7455791 0.78 ACHE (0.31) ACHE
SCHEMBL7460565 0.78 ACHE (0.31) ACHE
SCHEMBL30305775 0.78 ACHE (0.39) ACHEHTTKDM4CTSHR
SCHEMBL5670548 0.77 GABRA1 (0.33) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5444134-A Using a coordination catalyst IDEMITSU KOSAN CO., LTD. (JP) 1995-08-22 US claimed
US-6414090-B1 None US disclosed
US-20240308936-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2024-09-19 US disclosed
EP-4385972-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION Idemitsu Kosan Co.,Ltd. (JP) 2024-06-19 EP disclosed
WO-2024116789-A1 LUBRICATING OIL COMPOSITION 出光興産株式会社 2024-06-06 WO disclosed
EP-3626869-B1 CRIMPED FIBERS AND NONWOVEN CLOTH IDEMITSU KOSAN CO (JP) 2024-04-24 EP disclosed
WO-2024080214-A1 METHOD FOR PRODUCING α-OLEFIN POLYMER 出光興産株式会社 2024-04-18 WO disclosed
US-20230235202-A1 PLASTICIZER FOR RESINS IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-27 US disclosed
US-11034826-B2 Polypropylene-based resin composition, pellet, and molded object IDEMITSU KOSAN CO., LTD. (JP) 2021-06-15 US disclosed
EP-3165656-B1 SPUNBONDED NON-WOVEN FABRIC AND METHOD FOR MANUFACTURING SAME IDEMITSU KOSAN CO (JP) 2021-05-12 EP disclosed
EP-0590486-A2 Polymerization catalysts and process for producing polymers IDEMITSU KOSAN COMPANY LIMITED (JP) 1994-04-06 EP disclosed
EP-0571987-A2 Process for producing an ethylenic polymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 EP disclosed
EP-0572003-A2 Process for producing an ethylenic polymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 EP disclosed
EP-0572034-A2 Ethylenic copolymer and ethylenic copolymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 EP disclosed
EP-0570931-A2 Styrenic polymer, process for producing same and multi-layer material comprising same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-24 EP disclosed
EP-0570932-A2 Styrenic block copolymer and process for producing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-24 EP disclosed
EP-0559108-A1 Graft copolymer, process for production thereof and resin composition containing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-09-08 EP disclosed
EP-0522581-A1 Process for producing olefin based polymers and olefin polymerization catalyst IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-01-13 EP disclosed
EP-0513380-A1 PROCESS FOR PRODUCING OLEFINIC POLYMER IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-11-19 EP disclosed
EP-0504418-A1 PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER, CYCLOOLEFIN COPOLYMER, AND COMPOSITION AND MOLDING PREPARED THEREFROM IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240308936-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION OXER1, AMY1A, MACF1 ACHE 3244/4885HTT 2361/4885KDM4C 4880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.